Navigation Links
ThreeWire Expands Presence in the Pharmaceutical Arena
Date:5/27/2008

Utilizes extensive experience in medical device industry to benefit

pharmaceutical clinical trial recruitment efforts

MINNEAPOLIS, May 27 /PRNewswire/ -- Leading clinical trial recruitment and direct-to-patient marketing firm ThreeWire has strengthened the pharmaceutical side of its business with the addition of two directors of business development and a commitment to leveraging differentiators unique to the medical device industry on behalf of pharmaceutical industry clients.

According to ThreeWire CEO and President, Mark Summers, "In the world of medical device clinical research studies, you have to motivate patients to agree to have a device surgically implanted in their body. Add to that a restrictive protocol, and you are now recruiting from a narrow, hard-to-reach patient population that must be prepared to undergo a highly invasive surgical procedure. Success depends on a system that targets only the most qualified patients and keeps them engaged throughout the healthcare continuum. It is that experience we are using to drive enrollment for pharmaceutical clinical trials."

In order to help pharmaceutical companies in their patient recruitment efforts, ThreeWire has hired Janine Katz and Shannon McDonnell. Katz is a business development professional with over ten years of experience in clinical trial patient recruitment and public relations programs in the pharmaceutical and healthcare industries. McDonnell brings leadership skills in business development in the healthcare field, including two years focused solely on clinical trial recruitment. Both will report to Jim Suddendorf, Senior Vice President, Business Development and Client Services.

"As the regulatory bar is being raised and greater numbers of patients are being required for trial completion, the challenge of patient recruitment is being elevated," adds Suddendorf. "Successful enrollment solutions depend on a systematic marketing approach, which is exactly what ThreeWire offers."

To deliver results, ThreeWire offers a full array of in-house services, including concept development, advertising, media planning and buying, and optimized website development, as well as site-based support and portal tools. Contract study coordinators can conduct patient record screenings, process patient referrals and assist with informed consent. ThreeWire also features a multi-lingual nurse-staffed call center and grassroots outreach.

For more information, contact sales@threewire.com.

Since 1999, ThreeWire has been delivering premier services and offering strategic and tactical solutions that result in measurable growth, global brand recognition and market leadership to the medical device, pharmaceutical and biotech industries. In addition to clinical trial recruitment and direct-to-patient marketing, ThreeWire also offers Recall Response Services with 24/7 call center capabilities.

For more information, contact:

Annie Garvey

952-852-5572

agarvey@threewire.com


'/>"/>
SOURCE ThreeWire
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
2. DuPont Expands Animal Health Solutions Business in Asia
3. Hospira Expands Board of Directors
4. Sidec AB Expands Into New Offices
5. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
6. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
7. Quintiles Consulting Business Expands
8. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
9. BrainCells Inc. Expands Series B Financing to $50 Million
10. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
11. SeqWright Expands Next Generation Lineup with the Addition of 454s GS FLX(TM) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):